Completed PHASE4 INTERVENTIONAL 3-arm NCT02577601

Impact of Combined Hormonal Contraceptives on UPA

Determining the Impact of Combined Hormonal Contraceptives on Ulipristal Acetate

Sponsor: Oregon Health and Science University

Interventions Levonorgestrel (LNG)/Ethinyl estradiol birth control pill Ulipristal Acetate

Updated 12 times since 2017 Last updated: Oct 28, 2019 Started: Sep 8, 2015 Primary completion: Jun 17, 2017 Completion: Jun 17, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Contraception, this trial is completed. The trial is conducted by Oregon Health and Science University and has accumulated 12 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 7 earlier versions

Dec 2019 — Jan 2021 [monthly]

Completed PHASE4
Jan 2019 — Dec 2019 [monthly]

Completed PHASE4
Sep 2018 — Jan 2019 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE4
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Sep 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oregon Health and Science University
Society of Family Planning

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States